Terms: = Liver cancer AND BCL2, Bcl-2, 596, ENSG00000171791 AND Clinical Outcome
15 results:
1. Risk factors and clinical outcomes of extrahepatic recurrence in patients with post-hepatectomy recurrent hepatocellular carcinoma.
Li J; Huang L; Liu C; Qiu M; Yan J; Yan Y; Wei S
ANZ J Surg; 2021 Jun; 91(6):1174-1179. PubMed ID: 33724680
[TBL] [Abstract] [Full Text] [Related]
2. Breviscapine ameliorates CCl4‑induced liver injury in mice through inhibiting inflammatory apoptotic response and ROS generation.
Liu Y; Wen PH; Zhang XX; Dai Y; He Q
Int J Mol Med; 2018 Aug; 42(2):755-768. PubMed ID: 29717768
[TBL] [Abstract] [Full Text] [Related]
3. Upregulated TRIO expression correlates with a malignant phenotype in human hepatocellular carcinoma.
Wang B; Fang J; Qu L; Cao Z; Zhou J; Deng B
Tumour Biol; 2015 Sep; 36(9):6901-8. PubMed ID: 25851347
[TBL] [Abstract] [Full Text] [Related]
4. Aberrant deleted in liver cancer-1 expression is associated with tumor metastasis and poor prognosis in urothelial carcinoma.
Chen WT; Yang CH; Wu CC; Huang YC; Chai CY
APMIS; 2013 Dec; 121(12):1131-8. PubMed ID: 23510351
[TBL] [Abstract] [Full Text] [Related]
5. Decrease of survivin, p53 and bcl-2 expression in chemorefractory colorectal liver metastases may be predictive of radiosensivity radiosensivity after radioembolization with yttrium-90 resin microspheres.
Melucci E; Cosimelli M; Carpanese L; Pizzi G; Izzo F; Fiore F; Golfieri R; Giampalma E; Sperduti I; Ercolani C; Sciuto R; Mancini R; Garufi C; Diodoro MG; Mottolese M;
J Exp Clin Cancer Res; 2013 Mar; 32(1):13. PubMed ID: 23497522
[TBL] [Abstract] [Full Text] [Related]
6. Combined anti-tumor effects of IFN-α and sorafenib on hepatocellular carcinoma in vitro and in vivo.
Wang L; Jia D; Duan F; Sun Z; Liu X; Zhou L; Sun L; Ren S; Ruan Y; Gu J
Biochem Biophys Res Commun; 2012 Jun; 422(4):687-92. PubMed ID: 22634008
[TBL] [Abstract] [Full Text] [Related]
7. Coexpression of bcl-2 with epithelial-mesenchymal transition regulators is a prognostic indicator in hepatocellular carcinoma.
Zhao N; Sun BC; Zhao XL; Liu ZY; Sun T; Qiu ZQ; Gu Q; Che N; Dong XY
Med Oncol; 2012 Dec; 29(4):2780-92. PubMed ID: 22460834
[TBL] [Abstract] [Full Text] [Related]
8. Expression of pro- and anti-inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV-genotype-4.
Zekri AR; Bahnassy AA; Abdel-Wahab SA; Khafagy MM; Loutfy SA; Radwan H; Shaarawy SM
J Gastroenterol Hepatol; 2009 Mar; 24(3):416-28. PubMed ID: 19054267
[TBL] [Abstract] [Full Text] [Related]
9. 18F-FDG PET scanning correlates with tissue markers of poor prognosis and predicts mortality for patients after liver resection for colorectal metastases.
Riedl CC; Akhurst T; Larson S; Stanziale SF; Tuorto S; Bhargava A; Hricak H; Klimstra D; Fong Y
J Nucl Med; 2007 May; 48(5):771-5. PubMed ID: 17475966
[TBL] [Abstract] [Full Text] [Related]
10. Bio-pathological factors of prognostic value in colorectal adenocarcinomas.
Mottolese M; Buglioli S; Piperno G; Sperduti I; Giannarelli D; D'Angelo C; Cosimelli M
J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):163-6. PubMed ID: 16767924
[TBL] [Abstract] [Full Text] [Related]
11. Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor.
Chang J; Clark GM; Allred DC; Mohsin S; Chamness G; Elledge RM
Cancer; 2003 Feb; 97(3):545-53. PubMed ID: 12548595
[TBL] [Abstract] [Full Text] [Related]
12. Rb, mcl-1 and p53 expression correlate with clinical outcome in patients with liver metastases from colorectal cancer.
Backus HH; van Riel JM; van Groeningen CJ; Vos W; Dukers DF; Bloemena E; Wouters D; Pinedo HM; Peters GJ
Ann Oncol; 2001 Jun; 12(6):779-85. PubMed ID: 11484952
[TBL] [Abstract] [Full Text] [Related]
13. Gallbladder carcinomas: an immunoprognostic evaluation of P53, bcl-2, CEA and alpha-fetoprotein.
Kanthan R; Radhi JM; Kanthan SC
Can J Gastroenterol; 2000 Mar; 14(3):181-4. PubMed ID: 10758414
[TBL] [Abstract] [Full Text] [Related]
14. Interferon-alpha induces bcl-2 proto-oncogene in patients with neuroendocrine gut tumor responding to its antitumor action.
Imam H; Gobl A; Eriksson B; Oberg K
Anticancer Res; 1997; 17(6D):4659-65. PubMed ID: 9494585
[TBL] [Abstract] [Full Text] [Related]
15. Cell proliferation-related markers in colorectal liver metastases: correlation with patient prognosis.
Costa A; Doci R; Mochen C; Bignami P; Faranda A; Gennari L; Silvestrini R
J Clin Oncol; 1997 May; 15(5):2008-14. PubMed ID: 9164212
[TBL] [Abstract] [Full Text] [Related]
